Sie befinden sich hier

Inhalt

Publications

Original Research Articles

  1. Sparano C, Solís-Sayago D, Zangger N, Rindlisbacher L, Van Hove H, Vermeer M, Westermann F, Mussak C, Rallo E, Dergun S, Litscher G,  Xu Y, Bijnen M, Friedrich C, Greter M, Juranić Lisnić V, Becher B, Gasteiger G, Oxenius A, Tugues S (2025). Autocrine TGF-β1 drives tissue-specific differentiation and function of resident NK cells.  J Exp Med, March 3.
  2. Wertheimer T, Zwicky P, Rindlisbacher L, Sparano C, Vermeer M, de Melo BMS, Haftmann C, Rückert T, Sethi A, Schärli S, Huber A, Ingelfinger F, Xu C, Kim D, Häne P, Fonseca da Silva A, Muschaweckh A, Nunez N, Krishnarajah S, Köhler N, Zeiser R, Oukka M, Korn T, Tugues S#, Becher B# (2024). IL-23 stabilizes an effector Treg cell program in the tumour microenvironment. Nat Immunol, Feb 14. # Equal contribution.
  3. Sparano C, Solis-Sayago D, Vijaykumar A, Rickenbach C, Vermeer M, Ingelfinger F, Fonseca A, Mussak C, Mayoux M, Friedrich C, Nombela-Arrieta C, Gasteiger G, Becher B, Tugues S (2022). Embryonic and neonatal waves generate distinct populations of hepatic ILC1s. Science Immunology, July 2.
  4. Ducimetiere L*, Lucchiari G*, Litscher G, Nater M, Heeb L, Núñez NG, Wyss L, Burri D, Vermeer M, Gschwendt G, Moor AE, Becher B, van den Broek M#, Tugues S# (2021). Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci USA, July 6.
  5. Ducimetiere L, Vermeer M, Tugues S (2019). The Interplay between innate lymphoid cells and the tumor microenvironment. Frontiers in Immunology, Dec 13.
  6. Tugues S*, Amorim A*, Spath S*, Martin-Blondel G, Schreiner B, De Feo D, Lutz M, Guscetti F, Apostolova P, Haftmann C, Hasselblatt P, Nunez N, Hottiger MO, van den Broek M, Manz MG, Zeiser R, Becher B (2018). GM-CSF-licensed myeloid cells mediate graft-vs-host disease uncoupling immunopathology from graft-vs-leukemia. Science Translational Medicine, Nov; 10:1-12.
  7. Ohs I, Ducimetiere L, Marinho J, Kulig P, Becher B#, Tugues S# (2017). Restoration of natural killer cell anti-metastatic activity by IL-12 and checkpoint blockade. Cancer Research, Dec; 77: 7059-7071. # Equal contribution.
  8. Ohs I, van den Broek M, Nussbaum K, Münz C, Arnold SJ, Quezada SA, Tugues S*, Becher B* (2016). Interleukin-12 bypasses common gamma-chain signaling in emergency natural killer cell lymphopoiesis. Nature Communications, Dec; 7:13708.
Nach obenDruckenImpressumDatenschutz